Biotechnology

Apr 21, 2017  |  Slate

The U.S. Regulations for Biotechnology Are Woefully Out of Date

The chronic challenge with biotechnology regulation is that it can’t keep up with the fast pace of innovation. Jennifer Kuzma, distinguished professor of public and international affairs and co-director of NC State's Genetic Engineering and Society Center, featured.

Mar 27, 2017  |  CBC Radio

Are we prepared for our gene altered future?

The impending genetic boom goes beyond CRISPR and could have very wide-reaching implications — from feeding billions, to curing disease, to improving animal welfare. Those are the upsides. They could also have dire unintended consequences, for human health or even by disrupting entire ecosystems. Jennifer Kuzma, School of Public and International Affairs, featured.

Mar 17, 2017  |  MIT Technology Review

5 Biotech Products U.S. Regulators Aren’t Ready For

A new report issued by the National Academy of Sciences says U.S. regulatory agencies need to prepare for new plants, animals and microbes that will hit the market in the next five to 10 years. “All these products have the potential to be beneficial, but the question is, how do they compare to the alternative?” says Jennifer Kuzma, co-director of the Genetic Engineering and Society Center at NC State University and a member of the National Academy of Sciences committee that prepared the report.

Dec 7, 2016  |  World Economic Forum

As Technology Advances, How Do We Avoid Losing Touch With Our Values?

Jennifer Kuzma, distinguished professor of social sciences at NC State and a member of the Global Future Council on Technology, Values and Policy, explains why we need to approach technology development with our core values in mind, and how we draft policy to reflect those values.

May 2, 2016

Kuzma Named to National Committee on Biotechnology

NC State University professor Jennifer Kuzma will lend her expertise to a national committee studying the future of genetic engineering. The National Academy of Sciences, Engineering and Medicine recently named Kuzma to the Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System.